Back to directory

DRUGS FOR NEGLECTED DISEASESINITIATIVE NORTH AMERICA INC

EIN: 20-8774179

NEW YORK, NY
$5M – $10M annual revenue
$2,501,704 in assets
Latest filing: 2024
Health

Audit History

TAIT, WELLER & BAKER LLP

Current audit firm

2 years

Tenure

Log in as a firm to see if this organization has an open RFP.

Is this your organization?

Claim this profile to post RFPs, receive proposals from vetted accounting firms, and manage your audit search — all for free.

Sign up to claim this profile
DRUGS FOR NEGLECTED DISEASESINITIATIVE NORTH AMERICA INC